Ozempic and Wegovy for Women Over 40: What You Need to Know

In recent years, medications like Ozempic (semaglutide) and Wegovy have taken the wellness and weight loss world by storm. Originally developed to manage type 2 diabetes, these GLP-1 receptor agonists have shown significant success in reducing weight — but how do they perform specifically for women over 40?

Is it a shortcut or a breakthrough? Let’s explore the science, benefits, risks, and critical considerations.

What Are Ozempic and Wegovy?

Both Ozempic and Wegovy contain semaglutide, a compound that mimics the hormone GLP-1. This hormone:

  • Regulates blood sugar

  • Slows gastric emptying

  • Reduces appetite

Ozempic is primarily prescribed for type 2 diabetes, while Wegovy is approved specifically for chronic weight management.

Why Women Over 40 Are Exploring These Options

At 40 and beyond, hormonal changes, slowed metabolism, and lifestyle stressors make weight management increasingly challenging. Oestrogen levels drop, insulin resistance may rise, and muscle mass often declines.

“It becomes harder to maintain a healthy weight, even with good diet and exercise habits. Medications like Wegovy offer another tool in the toolkit,” says Dr Barbara Taylor, endocrinologist.

For women who have tried lifestyle changes without success, these medications may offer renewed hope.

Benefits Observed in Women 40+

  • Significant weight loss: Clinical trials show up to 15% total body weight loss with Wegovy.

  • Improved insulin sensitivity: Especially beneficial for those with PCOS or perimenopausal insulin resistance.

  • Appetite regulation: Helps reduce emotional eating and binge tendencies.

  • Cardiovascular benefits: Reduced risk factors like blood pressure and LDL cholesterol.

Risks and Considerations

Like any medication, these drugs come with side effects and caveats.

Common side effects include:

  • Nausea and vomiting

  • Diarrhoea or constipation

  • Headaches and fatigue

  • Risk of gallbladder issues

Serious risks (though rare):

  • Pancreatitis

  • Thyroid C-cell tumours (observed in animal studies)

  • Hypoglycaemia (especially if taken with insulin or other diabetic medications)

“GLP-1 agonists can be transformative, but they’re not a quick fix. They must be part of a larger conversation about health, nutrition, and support,” says Dr Aviva Romm, integrative physician.

Not for Everyone

Women who are pregnant, breastfeeding, or have a personal or family history of thyroid cancer should avoid these medications. They are also not intended for cosmetic weight loss in people with a healthy BMI.

The Mindset Shift: Medicine + Lifestyle

These medications do not replace a healthy lifestyle. In fact, sustainable success depends on nutrition, movement, stress management, and emotional wellbeing.

Best practice includes:

  • Working with a GP or endocrinologist

  • Seeing a dietitian or health coach

  • Tracking progress and adjusting goals

Final Thoughts: Should You Consider Ozempic or Wegovy?

If you’re a woman over 40 struggling with weight-related health issues despite trying everything, these medications may be worth exploring — with the guidance of a healthcare provider.

They are not miracle drugs, but when used responsibly, they can be a catalyst for lasting change.

“This is about metabolic reset, not magic. It’s still your journey, your effort, and your transformation,” says Nicole Montgomery, founder of Aesthetic Alchemist.

Always consult your GP or medical specialist before beginning any new prescription, especially if you have underlying conditions or are taking other medications.

Stay tuned with Aesthetic Alchemist for evidence-based insights and expert-backed support tailored for women in midlife and beyond.

ABM Media

Where the aesthetic industry comes to grow.

Business education, industry news and insights for aesthetic professionals across Australia.

Keep reading

You might also like.

REJURAN® Showcases Global Clinical Education at Aesthetics 2026 Sydney

REJURAN® Showcases Global Clinical Education at Aesthetics 2026 Sydney

REJURAN® Australia and New Zealand will showcase an international clinical education program at Aesthetics 2026 in Sydney, bringing together globally recognised experts from South Korea alongside Australian and New Zealand clinicians. The educational program includes the REJURAN® Clinical Masterclass exploring polynucleotide science, skin quality, skin longevity, live demonstrations and evidence-based treatment planning for healthcare professionals.